Form 4: Procter & Gamble Executive Jennifer L. Davis Reports Changes in Beneficial Ownership

Jennifer L. Davis, CEO Health Care at Procter & Gamble, filed a Form 4 detailing changes in her beneficial ownership of company stock and derivative securities.

Summary

• On August 5, 2024, Jennifer L. Davis, CEO Health Care at Procter & Gamble, filed a Form 4 with the SEC.
• The filing reports changes in her beneficial ownership of Procter & Gamble common stock and derivative securities, specifically Restricted Stock Units (RSUs).
• The transactions include the acquisition of RSUs representing a contingent right to receive P&G common stock or cash settlement.
• Davis directly owns 47,466.2367 shares of common stock.
• She indirectly owns 14,498.0702 shares through a retirement plan trustee and 4,351.1121 Series A Preferred Stock through a retirement plan trustee.
• She also acquired 783 Restricted Stock Units on August 1, 2024, as a retirement award.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing, indicating neutral sentiment. It simply reports transactions and holdings.

Positives

• The reporting person's holdings in the company have increased through the acquisition of Restricted Stock Units.

Future Outlook

The Restricted Stock Units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the holdings of a key executive.

Key Dates